Cyclic nucleotides, prostaglandins, and ischemic heart disease.
D015121:6-Ketoprostaglandin F1 alpha / Q000097:blood; D000818:Animals; D001161:Arteriosclerosis / Q000503:physiopathology; D003327:Coronary Disease / Q000097:blood / Q000188:drug therapy / Q000503:physiopathology*; D004036:Diet, Atherogenic; D009200:Myocardial Contraction; D009203:Myocardial Infarction / Q000503:physiopathology; D009712:Nucleotides, Cyclic / Q000097:blood / Q000502:physiology*; D011453:Prostaglandins / Q000502:physiology*; D011817:Rabbits; D013876:Thiophenes / Q000627:therapeutic use; D013928:Thromboxane A2 / Q000009:adverse effects / Q000097:blood / Q000502:physiology; D013988:Ticlopidine
D009712:Nucleotides, Cyclic; D011453:Prostaglandins; D013876:Thiophenes; D013928:Thromboxane A2; D015121:6-Ketoprostaglandin F1 alpha; D013988:Ticlopidine